NPPB and hydrops fetalis: Pufulete et al. indicated that the efficacy of BNP-guided therapy in specialist HF clinics is uncertain and in the cost-effectiveness model, in patients aged < 75 years with HFrEF or HFpEF, BNP-guided therapy improves median survival with a small QALY gain but higher lifetime costs [39].